Neuro Pioneers on a Quest to Cure
Menu
Home
Close
Our company
Our Story
Pipeline
People
Culture
Patients
Platform
FlexASO®
Platform
Explore More
Team
People
Pipeline
Pipeline
Culture
Culture
Patients
Patients
Latest Press Releases
February 23, 2026
QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS
December 29, 2025
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
December 18, 2025
QurAlis Invited to Present at 44th Annual J.P. Morgan Healthcare Conference
December 2, 2025
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting
